HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.
Hematopoietic stem cell transplantation (HSCT) still remains the only definitive cure currently available for patients with thalassemia and sickle cell anemia. Results of transplant in thalassemia and in sickle cell anemia have steadily improved over the last two decades due to improvements in pr...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
PAGEPress Publications
2009-12-01
|
| Серии: | Mediterranean Journal of Hematology and Infectious Diseases |
| Предметы: | |
| Online-ссылка: | http://www.mjhid.org/index.php/mjhid/article/view/114 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
